102.645 articles found

Levodopa-Responsive Parkinsonism Preceded by Isolated Upper Limb Tremor Associated with PTEN Variant.

Gandhi SE, Siripurapu R, Smith A, Kobylecki C.

Mov Disord Clin Pract · 2026-09-28

DOI: 10.1002/mdc3.70844PMID: 42806734

Nutritional education program counseling based on the Mediterranean diet on intestinal constipation in people with Parkinson's disease: a randomized clinical trial.

Fernandez RD, da Silva Mesquita F, Ferreira GC, Santos-Lobato BL.

Parkinsonism Relat Disord · 2026-09-28

DOI: 10.1016/j.parkreldis.2026.109003PMID: 42815344

Tonic-dominant sleep bruxism in multiple system atrophy: A polysomnographic comparison with Parkinsonian-related disorders.

Umemoto G, Yoshimura C, Fujioka S, Dotsu Y, Miyachi R, Kuchiishi M, Tsuboi Y, Fujita M.

Parkinsonism Relat Disord · 2026-09-28

DOI: 10.1016/j.parkreldis.2026.109002PMID: 42815345

Oleandrin and PBI-05204 for Neuroprotection in Alzheimer's Disease, Parkinson's Disease, and Stroke: Preclinical Mechanisms, Blood-brain Barrier Penetration, and Clinical Translation Perspectives.

Pal T, Singh P.

Mini Rev Med Chem · 2026-09-28

DOI: 10.2174/0113895575485020260907153210PMID: 42816980

Quantitative FP-CIT PET analysis of dopaminergic degeneration in isolated REM sleep behavior disorder and early Parkinson's disease.

Park HR, Kim J, Youn J, Choi JY, Moon SH, Joo EY.

Sleep Med · 2026-09-28

DOI: 10.1016/j.sleep.2026.109292PMID: 42826683

MRI-derived choroid plexus volume and longitudinal cognitive decline in Parkinson's disease.

Lv QK, Zhou ZQ, Shi LY, Gao F, Wang F, Cheng XY, Zhang JR, Chen Y, Mao CJ, Liu CF.

Parkinsonism Relat Disord · 2026-09-28

DOI: 10.1016/j.parkreldis.2026.109006PMID: 42837908

Subthalamic nucleus beta oscillations and sleep disorders in Parkinson's disease: A new perspective on deep brain stimulation regulation mechanisms and circuits.

Huang H, Ruan P, Wang Y, Liu Z, Wu Y, Zhang Z, Jiang X, Fu P.

Parkinsonism Relat Disord · 2026-09-28

DOI: 10.1016/j.parkreldis.2026.109001PMID: 42844068

Integrated Experimental and Computational Investigation of Fluorinated Benzoylthiourea Derivatives: Structural Characterization, Hirshfeld Surface Analysis, Antioxidant Activity, and MAO-B Inhibitory Potential for Parkinson's Disease.

Gul L, Solmaz U, Arslan H.

ACS Omega · 2026-09-28

DOI: 10.1021/acsomega.6c07002PMID: 42890068

Dopamine Metabolism as a Chemically Constrained Network: Structural Regulation, Redox Liability and Dopaminergic Vulnerability in Parkinson’s Disease

Ortega-Robles E, Guerra-Crespo M, Arias-Carrión O.

Medical sciences (Basel, Switzerland) · 2026-09-27

Dopamine Metabolism as a Chemically Constrained Network: Structural Regulation, Redox Liability and Dopaminergic Vulnerability in Parkinson's Disease.

Ortega-Robles E, Guerra-Crespo M, Arias-Carrión O.

Medical sciences (Basel, Switzerland) · 2026-09-27

DOI: 10.3390/medsci14060608PMID: 42930527

Ambroxol in Gaucher disease and GBA1-related Parkinson disease: an updated systematic review.

Lipiński P, Jezela-Stanek A, Tylki-Szymańska A.

Acta Neurol Belg · 2026-09-27

DOI: 10.1007/s13760-026-03202-wPMID: 42801449

Comparative study of Parkinson's disease phenotypes in homozygous and heterozygous LRRK2-G2019S mutation carriers.

Abida Y, Sghaier I, Gharbi A, Souissi A, Elloumi M, Atrous A, Gargouri A, Kacem I, Gouider R.

Acta Neurol Belg · 2026-09-27

DOI: 10.1007/s13760-026-03203-9PMID: 42801451